| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $40.0M | +127.0% |
| SG&A Expense | $7.5M | -41.4% |
| Operating Income | -$47.5M | -56.2% |
| Pre-tax Income | -$37.8M | +14.4% |
| Income Tax | $613K | +103.7% |
| Net Income | -$38.4M | +13.6% |
| EPS (Basic) | -$2.96 | +18.5% |
| EPS (Diluted) | -$2.96 | +18.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.1M | -71.2% |
| Short-term Investments | $17.9M | -55.0% |
| Inventory | $0 | — |
| Current Assets | $25.6M | -59.0% |
| Total Assets | $26.3M | -60.7% |
| Current Liabilities | $13.5M | +49.1% |
| Long-term Debt | $11.2M | -11.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$39.3M | -112.9% |
| Capital Expenditures | $13K | -79.0% |
| Investing Cash Flow | $23.3M | +67.2% |
| Financing Cash Flow | $1.0M | +156.9% |
| Free Cash Flow | -$39.3M | -112.3% |
| Total Liabilities |
| $32.7M |
| -15.9% |
| Stockholders' Equity | -$6.4M | -122.9% |